Clinical Trial: Page 2

AI-powered blood test supports risk stratification of heart disease patients
By Nick Paul Taylor
A blood test powered by artificial intelligence (AI) has shown promise in the assessment of patients with total blockage of a heart artery.
November 27, 2023
Heart Pulmonary Trunk Social
PLK1 inhibitors show promise for inflammatory disease treatment, study shows
By Matt Limb
A cancer drug in late-stage clinical trials could offer hope for treating a wide range of inflammatory diseases, including gout and heart disease, say researchers.
November 14, 2023
Molecule Social
Targeting feeder cells reverses prostate cancer’s resistance to treatment in study
By Matt Limb
Scientists have found a way to reverse prostate cancer’s resistance to drugs in research, which they say could have a broad impact across multiple cancer types.
October 24, 2023
Cancer Cells Prostate Social
Study launched on early intervention with immune modulators in COVID-19
By LabPulse.com staff writers
A clinical trial has been launched to determine if there are benefits to early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness.
September 26, 2023
Coronavirus Covid Blue Social
HIV vaccine trial begins enrollment in U.S., South Africa
By LabPulse.com staff writers
A clinical trial for a preventive HIV vaccine has begun enrollment in both the U.S. and South Africa.
September 25, 2023
Vial Vaccine Vial Tech Social
NIH starts early-phase trial of second-generation universal flu vaccine candidate
By Nick Paul Taylor
The U.S. National Institutes of Health (NIH) has begun an early-phase clinical trial of its second-generation universal flu vaccine candidate.
September 20, 2023
Needle Shot Vaccine Teenager Social
Moderna’s mRNA flu shot yields promising results in phase III trial
By LabPulse.com staff writers
Moderna announced that its mRNA flu shot that is in development has met its primary endpoints in a phase III trial, generating a stronger immune response than a commercially available flu vaccine.
September 15, 2023
Vaccine Injection Woman Social
Roche’s Alecensa improves survival in postsurgery lung cancer patients in late-phase trial
By Nick Paul Taylor
Roche’s Alecensa has improved disease-free survival in non-small cell lung cancer patients, positioning the Swiss drugmaker to apply to expand the product label.
September 8, 2023
Cancer Lung Social
Twist Bioscience, Ono Pharmaceutical to collaborate on autoimmune disease drug development
By LabPulse.com staff writers
Synthetic biology and genomics company Twist Bioscience has entered into a collaboration with Ono Pharmaceutical, one of the largest pharmaceutical companies in Japan, to discover and develop drugs for autoimmune diseases.
September 5, 2023
Test Tube Liquid Sample Social
Oral therapy combination yields promising results in multiple myeloma study
By LabPulse.com staff writers
A new agent that can be taken once daily in pill form showed promising results in a clinical trial when used in combination with a steroid in patients with multiple myeloma who had relapsed and stopped responding to currently available therapies.
September 1, 2023
Multiple Myeloma Social
Grail partners with LGBTQ+ group on study of cancer detection blood test
By Nick Paul Taylor
Grail has partnered with the Whitman-Walker Institute and the Cancer Support Community to assess the feasibility of using its multicancer early detection (MCED) Galleri blood test in a real-world setting.
September 1, 2023
Cancer Cell Microenvironment Social
Roche data release raises hopes TIGIT drugs can improve lung cancer survival
By Nick Paul Taylor
Roche's inadvertent release of interim data from its ongoing late-phase clinical trial has raised hopes that its anti-TIGIT immunotherapy may improve the survival rate of lung cancer patients.
August 25, 2023
Lung Cancer Hotspot Social
Previous Page
Page 2 of 18
Next Page